Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111254572 | 11125457 | 2 | F | 20160915 | 20150520 | 20160920 | PER | US-PFIZER INC-2015162890 | PFIZER | 65.00 | YR | F | Y | 82.00000 | KG | 20160920 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111254572 | 11125457 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | U | 21446 | 150 | MG | CAPSULE, HARD | TID | |||||
| 111254572 | 11125457 | 2 | C | LANTUS | INSULIN GLARGINE | 1 | 60 IU, 1X/DAY (AT BEDTIME) | 0 | 60 | IU | QD | ||||||||
| 111254572 | 11125457 | 3 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | UNK | 0 | |||||||||||
| 111254572 | 11125457 | 4 | C | NOVOLOG | INSULIN ASPART | 1 | UNK | 0 | |||||||||||
| 111254572 | 11125457 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, 1X/DAY | 0 | 100 | MG | TABLET | QD | ||||||
| 111254572 | 11125457 | 6 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, 1X/DAY, (IN THE EVENING) | 0 | 20 | MG | TABLET | QD | ||||||
| 111254572 | 11125457 | 7 | C | BENTYL | DICYCLOMINE HYDROCHLORIDE | 1 | Oral | 20 MG, AS NEEDED, (4 TIMES A DAY) | 0 | 20 | MG | TABLET | |||||||
| 111254572 | 11125457 | 8 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | UNK, 1X/DAY, (20 MG;TAKE 1.5 TABLETS) | 0 | TABLET | QD | ||||||||
| 111254572 | 11125457 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 40 MG, DAILY | 0 | 40 | MG | TABLET | ||||||||
| 111254572 | 11125457 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 60 MG, AS NEEDED, (EVERY DAY) | 0 | 60 | MG | TABLET | |||||||
| 111254572 | 11125457 | 11 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK, DAILY, (20MG, 1.5 TABLET DAILY) | 0 | TABLET | ||||||||||
| 111254572 | 11125457 | 12 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 4 MG, 2X/DAY | 0 | 4 | MG | BID | |||||||
| 111254572 | 11125457 | 13 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | Oral | 50 MG, AS NEEDED | 0 | 50 | MG | TABLET | |||||||
| 111254572 | 11125457 | 14 | C | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Subcutaneous | UNK, DAILY, (100 UNIT/M, 60 UNITS,AT BED) | 0 | ||||||||||
| 111254572 | 11125457 | 15 | C | LOMOTIL | ATROPINE SULFATEDIPHENOXYLATE HYDROCHLORIDE | 1 | Oral | 1 DF, AS NEEDED, (TWICE A DAY, ATROPINE SULFATE: 0.025MG-DIPHENOXYLATE HYDROCHLORIDE:2.5MG) | 0 | 1 | DF | TABLET | |||||||
| 111254572 | 11125457 | 16 | C | MUCINEX | GUAIFENESIN | 1 | Oral | 600 MG, AS NEEDED, (BID) | 0 | 600 | MG | ||||||||
| 111254572 | 11125457 | 17 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, DAILY, (EVENING) | 0 | 20 | MG | ||||||||
| 111254572 | 11125457 | 18 | C | PROVENTIL HFA | ALBUTEROL SULFATE | 1 | 2 DF, AS NEEDED, (2 PUFFS EVERY 4 HOURS) | 0 | 2 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111254572 | 11125457 | 1 | Neuropathy peripheral |
| 111254572 | 11125457 | 5 | Blood uric acid increased |
| 111254572 | 11125457 | 7 | Abdominal pain |
| 111254572 | 11125457 | 9 | Peripheral swelling |
| 111254572 | 11125457 | 13 | Migraine |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111254572 | 11125457 | Drug effect incomplete |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111254572 | 11125457 | 1 | 2010 | 0 |